Reset Map4 Results
1 Broadway 14th Floor Cambridge, Massachusetts, 02142 United StatesLikarda is a cell therapy and delivery R&D company with expertise in cell-based products. We have developed a number of innovations in this area over the years and are moving many in our pipeline to the clinic as therapeutics in addition to growing our platform. Likarda’s foundational technology is based on cell encapsulation and delivery in hydrogels using our patented Core-Shell Spherification(TM) (CSS) system. Unlike technologies that utilize alginate or modify alginate (which is basically a bandaid for a temporary solution), Likarda utilizes readily available and biocompatible hydrogel materials such as hyaluronic acid, PEG, and a number of other chemistries to microencapsulate cells. These hydrogels are already being used and successful in wound healing, cosmetics, as dermal fillers, and in join viscosupplements. This can produce superior biocompatible cell-based treatments by either: (1) Durable: coating the cells in an immunoprotective barrier for injection/transplant for long-term treatments, or; (2) Degradable: injectable cell therapies in a slow-release, degradable formulation enabling localized cell release over time and increased efficacy. CSS if versatile, enabling both durable and degradable versions, and can be applied to several cell therapy indications for pets and humans. Likarda also has expertise in hydrogels in other formats as well. Our team has experience with chemistries of these materials and how to modify them in both microencapsulants and as bulk hydrogels to fit your needs.
10330 Hickman Mills Drive Suite B Kansas City, Missouri, 64137 United StatesLikarda is a cell therapy and delivery R&D company with expertise in cell-based products. We have developed a number of innovations in this area over the years and are moving many in our pipeline to the clinic as therapeutics in addition to growing our platform. Likarda’s foundational technology is based on cell encapsulation and delivery in hydrogels using our patented Core-Shell Spherification(TM) (CSS) system. Unlike technologies that utilize alginate or modify alginate (which is basically a bandaid for a temporary solution), Likarda utilizes readily available and biocompatible hydrogel materials such as hyaluronic acid, PEG, and a number of other chemistries to microencapsulate cells. These hydrogels are already being used and successful in wound healing, cosmetics, as dermal fillers, and in join viscosupplements. This can produce superior biocompatible cell-based treatments by either: (1) Durable: coating the cells in an immunoprotective barrier for injection/transplant for long-term treatments, or; (2) Degradable: injectable cell therapies in a slow-release, degradable formulation enabling localized cell release over time and increased efficacy. CSS if versatile, enabling both durable and degradable versions, and can be applied to several cell therapy indications for pets and humans. Likarda also has expertise in hydrogels in other formats as well. Our team has experience with chemistries of these materials and how to modify them in both microencapsulants and as bulk hydrogels to fit your needs.
1 Broadway 14th Floor Cambridge, MA, 02142 United StatesLikarda is a cell therapy and delivery R&D company with expertise in cell-based products. We have developed a number of innovations in this area over the years and are moving many in our pipeline to the clinic as therapeutics in addition to growing our platform. Likarda’s foundational technology is based on cell encapsulation and delivery in hydrogels using our patented Core-Shell Spherification(TM) (CSS) system. Unlike technologies that utilize alginate or modify alginate (which is basically a bandaid for a temporary solution), Likarda utilizes readily available and biocompatible hydrogel materials such as hyaluronic acid, PEG, and a number of other chemistries to microencapsulate cells. These hydrogels are already being used and successful in wound healing, cosmetics, as dermal fillers, and in join viscosupplements. This can produce superior biocompatible cell-based treatments by either: (1) Durable: coating the cells in an immunoprotective barrier for injection/transplant for long-term treatments, or; (2) Degradable: injectable cell therapies in a slow-release, degradable formulation enabling localized cell release over time and increased efficacy. CSS if versatile, enabling both durable and degradable versions, and can be applied to several cell therapy indications for pets and humans. Likarda also has expertise in hydrogels in other formats as well. Our team has experience with chemistries of these materials and how to modify them in both microencapsulants and as bulk hydrogels to fit your needs.
10330 Hickman Mills Drive Suite B Kansas City, MO, 64137 United StatesLikarda is a cell therapy and delivery R&D company with expertise in cell-based products. We have developed a number of innovations in this area over the years and are moving many in our pipeline to the clinic as therapeutics in addition to growing our platform. Likarda’s foundational technology is based on cell encapsulation and delivery in hydrogels using our patented Core-Shell Spherification(TM) (CSS) system. Unlike technologies that utilize alginate or modify alginate (which is basically a bandaid for a temporary solution), Likarda utilizes readily available and biocompatible hydrogel materials such as hyaluronic acid, PEG, and a number of other chemistries to microencapsulate cells. These hydrogels are already being used and successful in wound healing, cosmetics, as dermal fillers, and in join viscosupplements. This can produce superior biocompatible cell-based treatments by either: (1) Durable: coating the cells in an immunoprotective barrier for injection/transplant for long-term treatments, or; (2) Degradable: injectable cell therapies in a slow-release, degradable formulation enabling localized cell release over time and increased efficacy. CSS if versatile, enabling both durable and degradable versions, and can be applied to several cell therapy indications for pets and humans. Likarda also has expertise in hydrogels in other formats as well. Our team has experience with chemistries of these materials and how to modify them in both microencapsulants and as bulk hydrogels to fit your needs.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.